Haleon, Pfizer and Sensodyne
Drug giant Pfizer sells $3.3 billion stake in Sensodyne-maker Haleon
Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil painkillers to 15% from 22.
Pfizer to offload about 6% stake in Sensodyne-maker Haleon
Pfizer intends to sell about 540 million shares in British consumer healthcare company Haleon, a bookrunner said on Monday, reducing the top shareholder's
Pfizer sells stake in Sensodyne and Panadol maker Haleon worth around £2.4bn
Pfizer sold 640 million shares in Haleon for 380p each, reducing its holding in the consumer healthcare firm by 7.6%
Pfizer to sell about $3.25 billion stake in Sensodyne-maker Haleon, bookrunner says
Pfizer's stake sale in British consumer healthcare company Haleon has been upsized by 100 million shares to 640 million shares worth about $3.25 billion with strong demand from investors, a bookrunner familiar with the offering said on Monday.
Sensodyne maker Haleon to raise stake in China JV
(Reuters) -Haleon plans to increase its stake in its Chinese joint venture to 88% from 55%, the British consumer healthcare company said on Friday. It will pay 4.47 billion yuan ($637 million) to buy the stake from partners Tianjin Pharmaceutical Group (TPG) and Tianjin Pharmaceutical Da Ren Tang Group (DRTG),
Pfizer Sells Shares in Haleon, Raising £2.43B in Share Sale
Pharmaceutical giant Pfizer Inc. announced on Tuesday that it has reduced its stake in British consumer healthcare company Haleon PLC by selling 640 million shares, raising approximately £2.43 billion ($3.
Drug giant Pfizer sells $3.3 bln stake in Sensodyne-maker Haleon
Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil painkillers to 15% from 22.
Pfizer sells $3.3 billion stake in Sensodyne-maker Haleon
Pfizer has sold a stake in British consumer healthcare group Haleon worth about $3.26 billion, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil painkillers to 15% from 22.
Pfizer Sells $3.26B Stake in Haleon
Pfizer Inc. ($PFE) has sold its stake worth $3.26 billion in UK-based consumer healthcare company Haleon PLC ($GB:HLN). With this transaction,
Pfizer cuts Haleon stake in $3.3B share sale
Pfizer (NYSE:PFE) has reduced its ownership in the British consumer healthcare giant Haleon (NYSE:HLN) to 15% from 22.6% by selling £2.45B ($3.26B) worth of company shares, Reuters reported Tuesday, citing a bookrunner.
Haleon buys back £230m of its shares as Pfizer sells down stake
Haleon said Pfizer's stake was expected to fall to 15 per cent from 22.6 per cent. Haleon shares fell 0.25 per cent or 1.00p to 391.90p, having risen around 15 per cent in the las
Pfizer Offloads $3.3 Billion Stake in Sensodyne-Maker Haleon
(Reuters) - Pfizer offloaded shares worth roughly $3.26 billion in Haleon at 380 pence apiece, cutting its stake to 15% in ...
World Street | Open AI's valuation soars to $150 bln, Pfizer's stake sale in Haleon, Yen weakens and more
From Tesla's persisting problems to Formula One and LVMH's latest 10-year long tie-up, here's a look at some of the major ...
Best Media9d
Sensodyne celebrates #DoctorsOfJoy this World Dentist's Day
DoctorsOfJoy aims to highlight how dentists empower individuals to fully enjoy life's moments by addressing oral health ...
Sensodyne Introduces All-In-One Care Toothpaste 'Sensodyne Complete Protection Plus'
Sensitive care toothpaste brand Sensodyne has launched an all-in-one care toothpaste 'Sensodyne Complete Protection Plus'.It ...